Carnival from A-Z concludes with the excitement of the Zulu ball that precedes by four days the annual parade. Back to the ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who ...

Global initiative addressing personalised and preventative health to be launched during the eventABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised ...

Accomplished physician-scientist brings more than 20 years of industry leadership experience and broad R&D expertise in multiple therapeutic areas SAN DIEGO, April 4, 2025 /PRNewswire/ ...

A Lenten Journey - You are invited to a weekly Reflection and Prayer meeting, during the Lenten Season in St. Ita’s Room of Clonard Community Centre from 7.30pm till 8.30pm every Friday until 11th ...

Forty years later it’s the turn of another French brand, Ekoi, to attempt to breathe new life into the humble pedal, in the shape of its large platform PW8 system. And the innovation doesn’t stop ...

In a report released today, Emily Field from Barclays maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price ...

The layoffs at the gene therapy company are part of restructuring of Spark Therapeutics by its owner, Roche Group.

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna, ...

FRANKFURT, April 2 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy benefit over the ...

Roche Holding AG said a high-dose version of Ocrevus, its best-selling multiple sclerosis drug, failed to outperform the ...